SH2 (Src Homology 2) domains are modular protein units that establish key protein-protein interactions and are therefore of high interest in drug discovery, particularly for oncological indications. SH2 domains recognize phosphotyrosine (pY)-containing peptide sequences, often as a mechanism for dimer formation, and subsequently regulate a range of cellular processes. A 2012 review by Liu et al., and our 2019 review with the Gunning group give a thorough overview of the general features of SH2 domains, the most important of which we have highlighted in Figure 1:
SH2db is an open-source database that aims to catalogue the structural information on SH2 domains in a way that is useful for medicinal chemists and structural biologists. Currently all human SH2 domains are collected and annotated (Figure 2). Grouping by functional categories is based on the work of Liu et al. SH2db is regularly updated with newly published PDB and AlphaFold structures of SH2 domains. All structures are aligned in two steps:
Inspired by GPCRdb, we have introduced a generic residue numbering scheme for SH2 domains, as follows:
If you use SH2db in your work, please cite our primary paper:
SH2db, an information system for the SH2 domain.
Bajusz D., Pándy-Szekeres G., Takács Á., de Araujo E.D., Keserű G.M.
Nucleic Acids Research, 2023, 51, W542–W552
SH2db is an open-source project, maintained by the Medicinal Chemistry Research Group (@keserulab) in Budapest, Hungary.
You can contribute to the project via GitHub:
You can contact us with any questions or suggestions regarding SH2db at sh2db ttk hu